Pfanstiehl Maltose M-132-1
Pfanstiehl Maltose M-132-1 is a disaccharide consisting of two glucose molecules with an α-1,4 glucosidic bond. Upon injection, it is only requires a minimal amount of insulin, having little impact influence on blood-sugar levels. Hence, it is commonly used to stabilize intravenous IG infusions, among other protein-based formulations. Pfanstiehl Brand, High Purity Low Endotoxin Maltose is a high quality, pharmaceutical grade maltose that can be used in bioprocessing and parenteral applications. In addition to use in nutritional intravenous fluids in certain countries, it can be also used as an excipient for protein stabilization.
Properties
- Pharma and Nutraceuticals Functions
- Bulking Agent
- Stabilizer
Product families
Applications
- Other Pharmaceutical Manufacturing Applications
Product Families
- Carriers & Bulking Agents
- Emulsifiers & Stabilizers
Other characteristics
- Synonyms
4-(alpha-D-glucopyranosido)-alpha-glucopyranose, 4-O-alpha-D-glucopyranosyl-D-glucopyranose, 4-O-alpha-D-glucopyranosyl-D-glucose, Maltobiose, Wheat Sugar
- Functions
- Bulking Agent, Stabilizer
- Certifications & Compliance
National Formulary (NF), United States Pharmacopeia (USP)
- Grade
- Pharma Grade
- Markets
- Healthcare & Pharma
- Applications
The applications of maltose include but are not limited to:; Blood Fractionation; Prevention of Protein Aggregation in IVIG solutions; Protein stabilization; Bulking agent
- Availability
Pfanstiehl Brand Maltose is available as USP-NF (United States Pharmacopeia—National Formulary). Pfanstiehl also holds a US DMF for Maltose.
- Technology
- Pharmaceuticals & Nutraceuticals
- Package Sizes
- 1kg, 5kg, 25kg, 50kg
- Certifications and Compliance
- National Formulary (NF)
- United States Pharmacopeia (USP)
